AT
TAK icon

Arlington Trust’s Takeda Pharmaceutical TAK Stock Holding History

Arlington Trust’s Portfolio TAK Stock Details TAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$256 Hold
16
– – ﹤0.01% 821
2026
Q1 		$296 Buy
+16
New +$281 ﹤0.01% 813
2025
Q3 		– Sell
-90
Closed -$1.39K – 698
2025
Q2 		$1.39K Buy
+90
New +$1.33K ﹤0.01% 578

Other funds holding TAK

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

Arlington Trust's TAK Position: Q2 2026 in Review

Arlington Trust held its Takeda Pharmaceutical (TAK) position steady in Q2 2026 at 16 shares worth $256. The position accounts for ﹤0.01% of the portfolio, ranked #821.

Arlington Trust first reported a position in TAK in Q2 2025 and has held it in 3 quarters since. The position peaked at $1.39K in Q2 2025. 376 funds tracked by Wall St. Rank hold TAK as of Q2 2026.

  • Arlington Trust held 16 shares of Takeda Pharmaceutical worth $256 as of Q2 2026.
  • Arlington Trust left its Takeda Pharmaceutical share count unchanged in Q2 2026.
  • Takeda Pharmaceutical made up ﹤0.01% of Arlington Trust's portfolio in Q2 2026, its #821 holding.
  • Arlington Trust first reported a position in Takeda Pharmaceutical in Q2 2025 and has held it in 3 quarters since.
  • Arlington Trust's Takeda Pharmaceutical position peaked at $1.39K in Q2 2025.
  • 376 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q2 2026.

Based on Arlington Trust's 13F filing for Q2 2026, filed 7 Jul 2026.